UnitedHealth, Salesforce Share Gains Contribute To Dow's 213-Point Climb

Dow Jones
Aug 15

DJ UnitedHealth, Salesforce Share Gains Contribute To Dow's 213-Point Climb

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of UnitedHealth and Salesforce are trading higher Friday morning, sending the Dow Jones Industrial Average into positive territory.

Shares of UnitedHealth (UnitedHealth Group Inc.) and Salesforce (Salesforce Inc.) have contributed about 50% of the blue-chip gauge's intraday rally, as the Dow (Dow Jones Industrial Average) is trading 213 points (0.5%) higher.

UnitedHealth's shares are up $32.10 (11.8%) while those of Salesforce are up $6.79, or 2.9%, combining for a roughly 239-point boost for the Dow.

Also contributing significantly to the gain are Merck (Merck & Co. Inc.), Procter & Gamble (Procter & Gamble Co.), and Amgen (Amgen Inc.).

A $1 move in any one of the 30 components of the index results in a 6.15-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled August 15, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

August 15, 2025 09:45 ET (13:45 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10